Aug 11, 2026 08:01AM
Jul 1, 2026 08:01AM
May 20, 2026 09:37AM
May 7, 2026 04:47PM
Mar 24, 2026 08:01AM
Jan 13, 2026 07:48AM
Dec 5, 2025 07:30AM Intensity Therapeutics gets 180-day Nasdaq extension until June 2026
Nov 7, 2025 04:41PM
Oct 30, 2025 07:30AM
Sep 10, 2025 07:47AM
Aug 20, 2025 07:37AM
Aug 12, 2025 03:16PM
Aug 4, 2025 07:47AM
Jun 12, 2025 05:00AM Intensity Therapeutics (INTS) Prices 6.675M Share Offering at $0.30/sh
Jun 11, 2025 04:07PM
Jun 11, 2025 08:34AM
May 21, 2025 08:48AM
May 19, 2025 11:32AM
May 13, 2025 04:10PM
Apr 25, 2025 08:00AM
Mar 19, 2025 07:34AM Benchmark Reiterates Speculative Buy Rating on Intensity Therapeutics, Inc. (INTS)
Mar 13, 2025 04:15PM
Jan 28, 2025 08:03AM
Dec 13, 2024 04:03PM
Nov 21, 2024 08:04AM
Nov 18, 2024 08:00AM
Sep 20, 2024 12:01PM
Aug 9, 2024 08:26AM Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 4c

447,651 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All